Chemical synthesis, docking studies and biological effects of functionalized 1,3-diaryl-2-propen-1-ones on human colon cancer cells

  • Guo-Min Zhu Department of Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006
  • Guo-Dong Huang Guo-Dong Huang, Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai Street, Nanchang, Jiangxi 330006
Keywords: 1, 3-Diaryl-2-propen-1-ones, Anticancer agents, Indolyl chalcones, colon cancer


A series of 1, 3-diaryl-2-propen-1-ones was synthesised in order to obtain a new type of anticancer drug, designed with hybrid features to inhibit colon cancer activated receptor. Based on computational modelling and docking studies, potential inhibitors were synthesised and their biological activity evaluated. The structures of newly synthesized compounds were confirmed by 1HNMR, 13CNMR and Mass spectrometry. All analogues were evaluated for in vitro cytotoxicity against human colon (caco-2) cancer cell lines. Compounds 1b, 1f-1h, and 2i showed significant cytotoxicity. Chalcones 1b, 1f and 1g were identified as the most potent and selective anticancer agents with IC50 values <1 µg/mL and 1.5 µg/mL, against caco-2 cell line, respectively. In conclusion, this finding confirms the suitability of indolyl chalcone analogues as candidates for further investigation towards the management of colon cancer related diseases.


Download data is not yet available.
980 Read


Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle. 2005; 4: 1201-15.

Agarwal A, Srivastava K, Puri SK, Chauhan PMS. Synthesis of substituted indole derivatives as a new class of antimalarial agents. Bioorg Med Chem Lett. 2005; 15: 3133.

Alqasoumi S I, Al-Taweel, AM, Alafeefy A M, Noaman E, Ghorab MM. Novel quinolines and pyrimido[4,5-b]quinolines bearing biologically active sulfonamide moiety as a new class of antitumor agents. Eur J Med Chem. 2010; 45: 738.

Ali Mohammad, Fauzia Bano Faruqi, Jamal Mustafa. Cancer: Possible prevention and chemotherapy by fatty materials: A review. Arc Apl Sci Res. 2009; 1: 178-99.

Alqasoumi SI, Al-Taweel AM, Alafeefy AM, Hamed MM, Noaman E, Ghorab MM. Synthesis and biological evaluation of 2-amino-7,7-dimethyl-4-substituted-5-oxo-1-(3,4,5-trimethoxy)-1,4,5,6,7,8-hexahydro-quinoline-3-carbonitrile derivatives as potential cytotoxic agents. Bioorg Med Chem Lett. 2009; 19: 6939.

Bhagat S, Sharma R, Sawant DM, Sharma L, Chakraborti AKJ. LiOH·H2O as a novel dual activation catalyst for highly efficient and easy synthesis of 1,3-diaryl-2-propenones by ClaisenSchmidt condensation under mild conditions. J Mol Catal A Chem. 2006; 244: 20.

Boeck P, Falca CAB, Leal PC, Yunes PA, Filho VC, Torres-Santos EC, Synthesis of chalcone analogues with increased anti-leishmanial activity. Bioorg Med Chem. 2006; 14: 153845.

Black DS, Renu BD, Kumar N. Synthesis of indol-3-yl-substituted 1-pyrroline 1-oxides. Aust J Chem. 1992; 45: 611.

Manna F, Chimenti F, Bolasco A, Bizzarri B, Filippelli W, Filippelli A, Gagliardi. L. Anti-inflammatory, analgesic and antipyretic 4,6-disubstituted 3-cyano-2-aminopyridines. Eur J Med Chem. 1999; 34: 245.

Cheng Y, An LK, Wu N, Wang XD, Bu XZ, Huang ZS, Gu LQ. Synthesis, cytotoxic activities and structureactivity relationships of topoisomerase I inhibitors: Indolizinoquinoline-5,12-dione derivatives. Bioorg Med Chem. 2008; 16: 4617.

Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3? in cellular signaling. Prog Neurobiol. 2001; 65: 391-426.

Cheenpracha S, Karalai C, Ponglimanont C, Subhadhirasakul S, Tewtrakul S. Anti-HIV- 1 protease activity of compounds from Boesenbergia pandurata. Bioorg Med Chem Lett. 2006; 14: 171014.

Dube D, Blouin M, Brideau C, Chan CC, Desmarais S, Ethier D, Falgueyret JP, Friesen RW, Girard M, Girard Y, Guay J, Riendeau D, Tagari P, Young RN. Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530. Bioorg Med Chem Lett. 1998; 8: 125561.

Dominguez JN, Leon C, Rodrigues J, Gamboa de Dominguez N, Gut J, Rosenthal PJ. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives. J Med Chem. 2005; 48: 365458.

Grugni M, Cassin M, Colella G, De Munari S, Pardi G, Pavesi P. Indole derivatives with antitumor activity. WO/2006/066923.

Jeong TS, Kim KS, An SJ, Lee S, Lee WS. Novel 3,5-diaryl pyrazolines as humanacyl-CoA: Cholesterol acyltransferase inhibitors. Bioorg Med Chem Lett. 2004; 14: 2715.

Kim YH, Shin K J, Lee TG, Kim E, Lee MS, Ryu SH, Suh PG. G2 arrest and apoptosis by 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS), a novel cytotoxic compound. Biochem Pharmacol. 2005; 69: 1333-41.

Kumar D, Kumar NM, Akamatsu K, Kusaka E, Harada H, Ito T. Synthesis and biological evaluation of indolyl chalcones as antitumor agents. Bioorg Med Chem Lett. 2010; 20: 391619.

Larsen RD, Corley EG, King AO, Carrol JD, Davis P, Verhoeven TR, Reider PJ, Labelle M, Gauthier JY, Xiang YB, Zamboni RJ. Practical route to a new class of LTD4 receptor antagonists. J Org Chem. 1996; 61: 3398-405.

Mulvihill MJ, Ji QS, Coate HR, Cooke A, Dong H, Feng L, Foreman K, Franklin M R, Honda A, Mak G, Mulvihill KM, Nigro AI, OConnor M, Pirrit C, Steinig AG, Siu K, Stolz KM, Sun Y, Tavares PA, Yao Y, Gibson NW. Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors. Bioorg Med Chem. 2008; 16: 1359-75.

Modzelewska A, Pettit C, Achanta G, Davidson NE, Huang P, Khan SR. Anticancer activities of novel chalcone and bis-chalcone derivatives. Bioorg Med Chem. 2006; 14: 3491-95.

Meng QC, Ni L, Worsencroft KJ, Ye J, Weingarten MD, Simpson JM, Skudlarek JW, Marino EM, Suen K Kunsch C, Souder A, Howard RB, Sundell CL, Wasserman MA, Sikorski JA. Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases. J Med Chem. 2007; 50: 1304-15.

Nerya O, Musa R, Khatib S, Tamir S, Vaya J. Chalcones as potent tyrosinase inhibitors: The effect of hydroxyl positions and numbers. Phytochemistry 2004; 65: 1384-95.

Nikolinakos P, Heymach JV. The tyrosine kinase inhibitor cediranib for nonsmall cell lung cancer and other thoracic malignancies. J Thorac Oncol. 2008; 3: 131-34

Prince HM, Bishton M, Panobinostat (LBH589): A novel pan-deacetylase inhibitor with activity in T cell lymphoma, hematology meeting reports. Vol. 3. Peter MacCallum Cancer Centre and University of Melbourne, Parkville, Australia, 2009, pp 33-38.

Roma G, Braccio MD, Grossi G, Mattioli F, Ghia M. 9-substituted N,N-dialkyl-5-(alkyl-amino or cycloalkylamino) [1,2,4]triazolo[4,3-a][1,8]naphthy-ridine-6-carboxamides, new compounds with anti-aggressive and potent anti-inflammatory activities. Eur J Med Chem. 2000; 35: 102135.

Stu AW, Marby TJ. Flavanoid front exudates from two Jamaican ferns, Pityrogramma tartarea and P. calomelanos. Phytochemistry 1971; 10: 2812-17.

Srinivasan B, Johnson TE, Lad R, Xing C. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities. J Med Chem. 2009; 52: 7228.

Svetaz L, Tapia A, Lopez SN, Furlan RLE, Petenatti E, Pioli R. Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi. J Agric Food Chem. 2004; 52: 3297300.

Yang HM, Shin HR, Cho SH, Bang SC, Song GY, Ju JH. Structural requirement of chalcones for the inhibitory activity of interleukin-5. Bioorg Med Chem. 2007; 15: 10411.

Yesuthangam Y, Pandian S, Venkatesan K, Gandhidasan R, Murugesan R. Photogeneration of reactive oxygen species and photoinduced plasmid DNA cleavage by novel synthetic chalcones. J Photochem Photobiol B Biol. 2011; 102: 20008.

Yoon H, Kim TW, Shin SY, Park MJ, Yong Y, Kim DW, Islam T, Lee YH, Jung KY, Lim Y. Design, synthesis and inhibitory activities of naringenin derivatives on human colon cancer cells. Bioorg Med Chem Lett. 2013; 23: 232-38.

Yadav DK, Kalani K, Singh AK, Khan F, Srivastava SK, Pant AB. Design, synthesis and in vitro evaluation of 18?-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7. Curr Med Chem. 2014; 21: 1160-70.

Yadav DK, Kalani K, Khan F, Srivastava SK. QSAR and docking based semi-synthesis and in vitro cytotoxic evaluation of glycyrrhetinic acid derivatives against human lung cancer cell line A549. Med Chem. 2013; 9: 1073-84.

How to Cite
Zhu, G.-M., and G.-D. Huang. “Chemical Synthesis, Docking Studies and Biological Effects of Functionalized 1,3-Diaryl-2-Propen-1-Ones on Human Colon Cancer Cells”. Bangladesh Journal of Pharmacology, Vol. 10, no. 1, Mar. 2015, pp. 230-4, doi:10.3329/bjp.v10i1.21699.
Research Articles